Top Markets
Coin of the day
Mosaic ImmunoEngineering Inc. Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering Inc.

CPMV
Classement en actions #38778
Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to... Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology. This innovative platform aims to provide therapeutic solutions for cancer and infectious diseases in both human and animal health. The company's core product is MIE-101, a nanoparticle-based treatment sourced from the cowpea mosaic virus, which has demonstrated non-infectious characteristics in mice, dogs, and humans. Headquartered in Novato, California, the company commenced operations in 2020.
Prix de l'action
$0.106
Dernière synchronisation: 2026-10-01
Capitalisation boursière
$767.67K
Changement (1 jour)
73.77%
Changement (1 an)
-84.81%
Pays
US
Échange Mosaic ImmunoEngineering Inc. (CPMV)

Catégorie

Ratio P/S pour Mosaic ImmunoEngineering Inc. (CPMV)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Mosaic ImmunoEngineering Inc., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Mosaic ImmunoEngineering Inc. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
10.51 -
US
34.29 -
US
3.77 -
AU
11.49 -
NL
- -
CH